Armata Pharmaceuticals, Inc. (ARMP) vs TuHURA Biosciences, Inc. (HURA)

Armata Pharmaceuticals, Inc. and TuHURA Biosciences, Inc. are both Biotechnology companies. Armata Pharmaceuticals, Inc. and TuHURA Biosciences, Inc. are of similar size ($136.5M and $133.8M). TuHURA Biosciences, Inc. has the higher net margin (0.00% vs −3,467.0%) and the higher return on invested capital (−74.2% vs −89.6%). Across the 13 metrics below, TuHURA Biosciences, Inc. leads on 8 and Armata Pharmaceuticals, Inc. on 5.

Valuation

Metric ARMP HURA Biotechnology median
P/E n/m n/m 7.88
P/S 24.46 n/m 11.47
P/B n/m 7.37 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 71.29 n/m 10.73
Earnings yield (143.90%) (25.71%) (28.84%)
Free cash flow yield (19.02%) (22.29%) (23.03%)

Profitability

Metric ARMP HURA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (734.19%) 0.00% 0.00%
Net margin (3,467.04%) 0.00% 0.00%
Free cash flow margin (465.34%) 0.00% 0.00%
Return on equity 127.83% (163.84%) (57.72%)
Return on assets (225.11%) (92.31%) (49.22%)
Return on invested capital (89.61%) (74.20%) 0.00%

Growth

Metric ARMP HURA Biotechnology median
Revenue growth (TTM) (19.29%) — 5.64%
EPS growth (last fiscal year) (1,398.60%) 47.93% —
Revenue growth, 5-year CAGR 42.90% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARMP HURA Biotechnology median
Debt to equity (1.23) 0.47 0.00
Current ratio 0.11 0.18 4.73
Net debt to EBITDA (7.07) 0.12 0.96

Dividend

Metric ARMP HURA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ARMP HURA Biotechnology median
Market cap 136.46m 133.83m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack